Related Tags >> Cancer Drugs Phase II GlaxoSmithKline Synta Pharmaceuticals

Paclitaxel News

Most Popular Paclitaxel Story

ALSO NOTED: Phyton cuts staff; Alzheimer's: A new indication for Enbrel?; and much more...

January 10, 2008 — 7:59am ET

> According to research released today, the anti-rheumatoid arthritis med Enbrel has shown an amazing ability to rehabilitate Alzheimer's patients. Read more...

Latest Headlines

Cephalon paying $10M in cancer tech deal
March 31, 2008
Avanti launches bionano company
March 28, 2008
ALSO NOTED: Phyton cuts staff; Alzheimer's: A new indication for Enbrel?; and much more...
January 10, 2008
Avastin re-submitted to FDA
August 24, 2007
Press Release: Phase III Trial of Nexavar Does Not Meet Primary Endpoint
December 3, 2006
SPOTLIGHT: Synta gets fast track for cancer therapy
November 14, 2006
Press Release: Synta Pharmaceuticals gets FDA Fast Track Designation for STA-4783
November 14, 2006
Editor's Corner
October 16, 2006
SPOTLIGHT: Synta trial hits endpoint
September 14, 2006
ALSO NOTED: Barr raises bid on Pliva; Synta touts new data; regulators question Factive rashes;and much more...
September 10, 2006
ALSO NOTED: FDA wants new NeoPharm trial; GSK may bid for Pfizer's OTC unit; and much more...
February 8, 2006
ALSO NOTED: FDA requires electronic drug labeling; Niccotine vaccine on the horizon; Cancer drug could fight scleroderma; and m
November 2, 2005
ALSO NOTED: FDA wants more safety data on Pargluva; Genentech disappointed by Tarceva, Avastin combo; Schering takes stake in S
October 17, 2005
ALSO NOTED: Altana acquires dermatology business; BioDelivery prices shares; NeoPharm touts new version of cancer drug; and muc
September 29, 2005
Sanofi-Aventis touts survival data in Taxotere study
August 18, 2005
Sonus shares surge as FDA approves Phase III design
July 7, 2005

Paid Research Reports